Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.32
Delayed Data
As of Aug 26
 -0.01 / -0.43%
Today’s Change
1.80
Today|||52-Week Range
10.50
-29.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues4.0M5.5M6.1M7.0M
 
 
 
 
 
Cost of Goods Sold2.8M4.1M3.5M3.7M
 
 
 
 
 
Depreciation And Amortization300.4K664.6K605.0K585.0K
 
 
 
 
 
 
Operating ExpensesGross Income897.1K728.6K2.0M2.7M
 
 
 
 
 
General Expenses6.2M7.1M7.1M6.7M
 
 
 
 
 
Research And Development1.5M1.2M1.5M1.7M
 
 
 
 
 
Total Operating Expenses9.3M11.9M11.3M11.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.3M-6.4M-5.2M-4.0M
 
 
 
 
 
Extraordinary Credit529.5K421.7K51.0K67.0K
 
 
 
 
 
Extraordinary Charge0.00-890.0K--0.00
 
 
Pre-Tax Equity Earnings-342.8K40.5K---15.0K
 
 
 
 
Interest Expense On Debt111.6K116.9K126.0K107.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.2M-6.9M-5.3M-4.0M
 
 
 
 
 
Income Taxes0.00-1.2M0.000.00
 
 
Net Income-5.2M-5.7M-5.3M-4.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M12.0M13.5M14.5M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M12.0M13.5M14.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.48-$0.39-$0.28
 
 
 
 
 
EPS Diluted-$0.56-$0.48-$0.39-$0.28